Application 208056
- Type
- NDA
- Sponsor
- TAKEDA PHARMS USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DEXILANT SOLUTAB | DEXLANSOPRAZOLE | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL | 30MG | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N208056-001 | DEXILANT SOLUTAB | DEXLANSOPRAZOLE | 30MG | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | RLD | 2016-01-26 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N208056-001 | 8461187 | 2026-01-17 | Drug product | 2016-02-25 | |
| N208056-001 | 9238029 | 2026-01-17 | Drug product | 2016-02-25 | |
| N208056-001 | 9011926 | 2026-02-24 | Drug product | 2016-02-25 | |
| N208056-001 | 8461187*PED | 2026-07-17 | Pediatric extension | ||
| N208056-001 | 8871273 | 2028-01-11 | Drug product | 2016-02-25 | |
| N208056-001 | 8871273*PED | 2028-07-11 | Pediatric extension | ||
| N208056-001 | 9241910 | 2029-03-10 | Drug product |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N208056-001 | DEXILANT SOLUTAB | 30MG | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | RLD | 2016-01-26 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N208056-001 | DEXILANT SOLUTAB | 30MG | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | RLD | 2016-01-26 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N208056-001 | DEXILANT SOLUTAB | 30MG | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | RLD | 2016-01-26 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N208056-001 | DEXILANT SOLUTAB | 30MG | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | RLD | 2016-01-26 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N208056-001 | DEXILANT SOLUTAB | 30MG | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | RLD | 2016-01-26 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N208056-001 | 8461187 | 2026-01-17 | Drug product | 2016-02-25 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N208056-001 | 9238029 | 2026-01-17 | Drug product | 2016-02-25 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N208056-001 | 9011926 | 2026-02-24 | Drug product | 2016-02-25 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N208056-001 | 8461187*PED | 2026-07-17 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N208056-001 | 8871273 | 2028-01-11 | Drug product | 2016-02-25 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N208056-001 | 8871273*PED | 2028-07-11 | Pediatric extension | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N208056-001 | 9241910 | 2029-03-10 | Drug product | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | N208056-001 | 8461187 | 2026-01-17 | Drug product | 2016-02-25 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N208056-001 | 9238029 | 2026-01-17 | Drug product | 2016-02-25 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N208056-001 | 9011926 | 2026-02-24 | Drug product | 2016-02-25 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N208056-001 | 8461187*PED | 2026-07-17 | Pediatric extension | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N208056-001 | 8871273 | 2028-01-11 | Drug product | 2016-02-25 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N208056-001 | 8871273*PED | 2028-07-11 | Pediatric extension | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N208056-001 | 9241910 | 2029-03-10 | Drug product | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | N208056-001 | 8461187 | 2026-01-17 | Drug product | 2016-02-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N208056-001 | 9238029 | 2026-01-17 | Drug product | 2016-02-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N208056-001 | 9011926 | 2026-02-24 | Drug product | 2016-02-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N208056-001 | 8461187*PED | 2026-07-17 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N208056-001 | 8871273 | 2028-01-11 | Drug product | 2016-02-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N208056-001 | 8871273*PED | 2028-07-11 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N208056-001 | 9241910 | 2029-03-10 | Drug product | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N208056-001 | 8461187 | 2026-01-17 | Drug product | 2016-02-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N208056-001 | 9238029 | 2026-01-17 | Drug product | 2016-02-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N208056-001 | 9011926 | 2026-02-24 | Drug product | 2016-02-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N208056-001 | 8461187*PED | 2026-07-17 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N208056-001 | 8871273 | 2028-01-11 | Drug product | 2016-02-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N208056-001 | 8871273*PED | 2028-07-11 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N208056-001 | 9241910 | 2029-03-10 | Drug product | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N208056-001 | 8461187 | 2026-01-17 | Drug product | 2016-02-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208056-001 | 9238029 | 2026-01-17 | Drug product | 2016-02-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208056-001 | 9011926 | 2026-02-24 | Drug product | 2016-02-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208056-001 | 8461187*PED | 2026-07-17 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N208056-001 | 8871273 | 2028-01-11 | Drug product | 2016-02-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208056-001 | 8871273*PED | 2028-07-11 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N208056-001 | 9241910 | 2029-03-10 | Drug product | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208056-001 | 8461187 | 2026-01-17 | Drug product | 2016-02-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208056-001 | 9238029 | 2026-01-17 | Drug product | 2016-02-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208056-001 | 9011926 | 2026-02-24 | Drug product | 2016-02-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208056-001 | 8461187*PED | 2026-07-17 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208056-001 | 8871273 | 2028-01-11 | Drug product | 2016-02-25 | 31067a03dcf5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dexlansoprazole delayed release | DEXLANSOPRAZOLE | REMEDYREPACK INC. | 55c550b4-eb8b-4e69-9c09-fa5125a52e65 | 2026-11-04 | Warnings, Adverse reactions | DEXLANSOPRAZOLE |
| Dexlansoprazole delayed release | DEXLANSOPRAZOLE | Aphena Pharma Solutions - Tennessee, LLC | 59e0c5d7-12e9-b5d7-e063-6394a90a7366 | 2026-08-25 | Warnings, Adverse reactions | DEXLANSOPRAZOLE |
| Dexlansoprazole delayed release | DEXLANSOPRAZOLE | Golden State Medical Supply, Inc. | f799b9b6-ba79-f335-e053-6294a90aaa68 | 2026-06-17 | Warnings, Adverse reactions | DEXLANSOPRAZOLE |
| Dexlansoprazole delayed release | DEXLANSOPRAZOLE | Bryant Ranch Prepack | dcfe880a-b96d-4a3c-aa21-3998d0bcfe9e | 2026-06-16 | Warnings, Adverse reactions | DEXLANSOPRAZOLE |
| Dexlansoprazole delayed release | DEXLANSOPRAZOLE | Upsher-Smith Laboratories, LLC | 8dca4887-c75a-4021-8564-b704e9e1fa3e | 2026-05-08 | Warnings, Adverse reactions | DEXLANSOPRAZOLE |
| Dexlansoprazole | DEXLANSOPRAZOLE | Par Health USA, LLC | d7452a26-db20-42fc-868a-a3e3606ca895 | 2026-04-13 | Warnings, Adverse reactions | DEXLANSOPRAZOLE |
| Dexlansoprazole delayed release | DEXLANSOPRAZOLE | Bryant Ranch Prepack | 31d3d485-5f87-4405-b940-490fa4ccf9cc | 2026-02-09 | Warnings, Adverse reactions | DEXLANSOPRAZOLE |
| Dexlansoprazole | DEXLANSOPRAZOLE | Alembic Pharmaceuticals Limited | 24c33ba6-bf47-434e-903e-f7ced98e030e | 2025-11-19 | Warnings, Adverse reactions | DEXLANSOPRAZOLE |
| Dexlansoprazole | DEXLANSOPRAZOLE | Alembic Pharmaceuticals Inc. | f9607c88-03b7-46c6-8b88-84f01dcf2221 | 2025-11-14 | Warnings, Adverse reactions | DEXLANSOPRAZOLE |
| Dexilant | DEXLANSOPRAZOLE | Takeda Pharmaceuticals America, Inc. | 9819f033-3bbe-442e-8e92-45fec77b237d | 2025-02-17 | Warnings, Adverse reactions | DEXLANSOPRAZOLE |
| Dexlansoprazole | DEXLANSOPRAZOLE | A-S Medication Solutions | fc3de800-bfad-4e2f-b664-d58a67550b2f | 2024-11-13 | Warnings, Adverse reactions | DEXLANSOPRAZOLE |
| Dexlansoprazole | DEXLANSOPRAZOLE | Bryant Ranch Prepack | caad4ada-2cf9-4e12-99df-6ca4388cf0f6 | 2024-01-29 | Warnings, Adverse reactions | DEXLANSOPRAZOLE |
| Dexlansoprazole | DEXLANSOPRAZOLE | Bryant Ranch Prepack | 3ed69e5a-aa78-4118-aa32-59a10f80c901 | 2024-01-05 | Warnings, Adverse reactions | DEXLANSOPRAZOLE |
| Dexlansoprazole delayed release | DEXLANSOPRAZOLE | A-S Medication Solutions | 7c7698da-3cda-4301-ae93-02fb64b9c90d | 2023-11-22 | Warnings, Adverse reactions | DEXLANSOPRAZOLE |
| Dexlansoprazole | DEXLANSOPRAZOLE | Mylan Pharmaceuticals Inc. | 3f9699b5-7614-41cb-bd1d-ff02930e98f3 | 2023-07-15 | Warnings, Adverse reactions | DEXLANSOPRAZOLE |
| Dexlansoprazole delayed release | DEXLANSOPRAZOLE | A-S Medication Solutions | 4f44e84f-6219-4445-a67d-df37d18b014d | 2023-06-06 | Warnings, Adverse reactions | DEXLANSOPRAZOLE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.